Acceleron Pharma Stock Current Ratio
Acceleron Pharma fundamentals help investors to digest information that contributes to Acceleron Pharma's financial success or failures. It also enables traders to predict the movement of Acceleron Stock. The fundamental analysis module provides a way to measure Acceleron Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acceleron Pharma stock.
Acceleron |
Acceleron Pharma Company Current Ratio Analysis
Acceleron Pharma's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Acceleron Pharma Current Ratio | 14.81 X |
Most of Acceleron Pharma's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acceleron Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Acceleron Pharma has a Current Ratio of 14.81 times. This is much higher than that of the Healthcare sector and 111.57% higher than that of the Biotechnology industry. The current ratio for all United States stocks is notably lower than that of the firm.
Acceleron Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acceleron Pharma's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acceleron Pharma could also be used in its relative valuation, which is a method of valuing Acceleron Pharma by comparing valuation metrics of similar companies.Acceleron Pharma is currently under evaluation in current ratio category among related companies.
Acceleron Fundamentals
| Return On Equity | -29.16 | |||
| Return On Asset | -16.73 | |||
| Profit Margin | (158.11) % | |||
| Operating Margin | (158.79) % | |||
| Current Valuation | 6.93 B | |||
| Shares Outstanding | 60.7 M | |||
| Shares Owned By Insiders | 11.86 % | |||
| Shares Owned By Institutions | 90.60 % | |||
| Number Of Shares Shorted | 2.12 M | |||
| Price To Earning | (14.74) X | |||
| Price To Book | 13.44 X | |||
| Price To Sales | 96.57 X | |||
| Revenue | 112.94 M | |||
| Gross Profit | (81.39 M) | |||
| EBITDA | (175.46 M) | |||
| Net Income | (178.56 M) | |||
| Cash And Equivalents | 687.25 M | |||
| Cash Per Share | 11.32 X | |||
| Total Debt | 22.43 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 14.81 X | |||
| Book Value Per Share | 13.37 X | |||
| Cash Flow From Operations | (151.71 M) | |||
| Short Ratio | 6.39 X | |||
| Earnings Per Share | (3.05) X | |||
| Number Of Employees | 312 | |||
| Beta | 0.35 | |||
| Market Capitalization | 10.91 B | |||
| Total Asset | 146.34 M | |||
| Retained Earnings | (381.51 M) | |||
| Working Capital | 96.44 M | |||
| Current Asset | 110.93 M | |||
| Current Liabilities | 14.49 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acceleron Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acceleron Pharma's short interest history, or implied volatility extrapolated from Acceleron Pharma options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Acceleron Stock
If you are still planning to invest in Acceleron Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acceleron Pharma's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |